Find clinical trials for Diabetes in Boston, MA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Diabetes trials near Boston, MA, USA:
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
Boston, Massachusetts, United States and 18 other locations
blood sugar levels in adults at high risk of developing type 2 diabetes (prediabetes).Research suggests that vitamin D may play a role in bl...
Phase 3
Boston, Massachusetts, United States
for youth 6 to \<18 years old with newly diagnosed stage 3 type 1 diabetes (T1D). The study will also evaluate the effect of an Afrezza plus...
Phase 2
Boston, Massachusetts, United States and 9 other locations
of the fully closed loop Omnipod M System in adults with type 2 diabetes using basal/bolus insulin therapy or basal-only insulin therapy, wi...
Boston, Massachusetts, United States and 26 other locations
OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...
Phase 2
Boston, Massachusetts, United States and 24 other locations
The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to pl...
Phase 3
North Dartmouth, Massachusetts, United States and 217 other locations
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...
Phase 4
Fall River, Massachusetts, United States and 89 other locations
enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive symptoms and glycemic control in adults with type 1 diabetes...
Boston, Massachusetts, United States and 2 other locations
The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.
Phase 3
East Providence, Rhode Island, United States and 89 other locations
pragmatic trial with open-label extension evaluating BT-001, an investigational digital therapeutic intended to help patients with type 2 diabetes...
Boston, Massachusetts, United States
Clinical trials
Research sites
Resources
Legal